International journal of molecular sciencesHumansHead and Neck NeoplasmsImmunotherapyClinical Trials as Topic
Immunotherapy in Head and Neck Cancer-Where Are We Now and Where Are We Headed?
Rafał Becht, Kajetan Kiełbowski, Paulina Żukowska, Robert Kowalczyk, Sebastian Ochenduszko, Inmaculada Maestu Maiques, Katarzyna Radomska
Published: 202610.3390/ijms27020987
Abstract
Head and neck cancer (HNC) encompasses tumors located within the oral cavity, sinonasal cavity, pharynx, and larynx. It is the sixth most common cancer worldwide. Current treatment methods in HNC patients involve radical surgery, radical radiotherapy…
Preview only. Read the full abstract at the source